Traders sold shares of CVS Health Corp (NYSE:CVS) on strength during trading on Tuesday. $93.37 million flowed into the stock on the tick-up and $138.21 million flowed out of the stock on the tick-down, for a money net flow of $44.84 million out of the stock. Of all companies tracked, CVS Health had the 31st highest net out-flow for the day. CVS Health traded up $0.51 for the day and closed at $78.61

CVS has been the topic of a number of recent research reports. Mizuho set a $95.00 target price on CVS Health and gave the company a “buy” rating in a report on Wednesday, June 13th. Royal Bank of Canada dropped their target price on CVS Health to $84.00 and set an “outperform” rating on the stock in a report on Friday, June 29th. Morgan Stanley decreased their price target on CVS Health from $88.00 to $80.00 and set an “overweight” rating on the stock in a research note on Tuesday, July 3rd. Citigroup restated a “buy” rating and issued a $81.00 price target on shares of CVS Health in a research note on Monday, July 9th. Finally, Leerink Swann set a $80.00 price target on CVS Health and gave the company an “outperform” rating in a research note on Thursday, August 9th. Two investment analysts have rated the stock with a sell rating, four have assigned a hold rating, eleven have issued a buy rating and two have given a strong buy rating to the company. The company presently has an average rating of “Buy” and an average price target of $86.85.

The company has a quick ratio of 1.87, a current ratio of 2.34 and a debt-to-equity ratio of 1.73. The company has a market cap of $78.30 billion, a price-to-earnings ratio of 13.21, a P/E/G ratio of 1.03 and a beta of 1.00.

CVS Health (NYSE:CVS) last posted its quarterly earnings results on Wednesday, August 8th. The pharmacy operator reported $1.69 earnings per share for the quarter, beating the Zacks’ consensus estimate of $1.61 by $0.08. The firm had revenue of $46.71 billion for the quarter, compared to the consensus estimate of $46.34 billion. CVS Health had a return on equity of 18.25% and a net margin of 1.61%. The company’s revenue for the quarter was up 2.2% compared to the same quarter last year. During the same period in the previous year, the business earned $1.33 earnings per share. analysts forecast that CVS Health Corp will post 7.05 EPS for the current fiscal year.

In related news, EVP Kevin Hourican sold 8,564 shares of the company’s stock in a transaction on Monday, August 27th. The stock was sold at an average price of $75.00, for a total value of $642,300.00. Following the completion of the transaction, the executive vice president now directly owns 12,135 shares in the company, valued at $910,125. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. 0.53% of the stock is owned by corporate insiders.

A number of institutional investors have recently added to or reduced their stakes in CVS. Ashburton Jersey Ltd increased its stake in CVS Health by 2.9% during the second quarter. Ashburton Jersey Ltd now owns 60,597 shares of the pharmacy operator’s stock worth $3,899,000 after acquiring an additional 1,711 shares during the last quarter. LFA Lugano Financial Advisors SA acquired a new stake in CVS Health during the second quarter worth about $176,000. Chicago Partners Investment Group LLC increased its stake in CVS Health by 9.8% during the second quarter. Chicago Partners Investment Group LLC now owns 12,292 shares of the pharmacy operator’s stock worth $791,000 after acquiring an additional 1,094 shares during the last quarter. Truvestments Capital LLC acquired a new stake in CVS Health during the second quarter worth about $1,474,000. Finally, WealthTrust Fairport LLC increased its stake in CVS Health by 29,115.8% during the second quarter. WealthTrust Fairport LLC now owns 5,551 shares of the pharmacy operator’s stock worth $357,000 after acquiring an additional 5,532 shares during the last quarter. Hedge funds and other institutional investors own 82.71% of the company’s stock.

CVS Health Company Profile (NYSE:CVS)

CVS Health Corporation, together with its subsidiaries, provides integrated pharmacy health care services. It operates through Pharmacy Services and Retail/LTC segments. The Pharmacy Services segment offers pharmacy benefit management solutions, such as plan design and administration, formulary management, Medicare Part D services, mail order, specialty pharmacy and infusion services, retail pharmacy network management services, prescription management systems, clinical services, disease management programs, and medical pharmacy management services.

See Also: What is the NASDAQ Stock Market?

Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.